Abstract
ABSTRACTSince the early 2000’, regulation agencies have encouraged viral vaccine manufacturers to implement in-process and real-time monitoring tools in production processes. Even if more assays have been recently developed, none of the novel viral particle quantification technologies can monitor virus levels and their secretion kinetics within production vessels. Vaccine manufacturers still rely on offline cell-based infectivity assays and antigen amount quantification to monitor their processes. The present study describes the development of the first automated biosensor for at-line monitoring of influenza virus production. It involves coupling a fetuin-based SPRi quantitative biosensor with an automated sampler of culture broth and a consecutive clarification setup via an acoustic filter. The SPRi response of different viral strains produced in two distinct cell production platforms was qualified. We demonstrated that fetuin-based quantitative SPRi is a robust, potency-indicating, and universal analytical technology for quantifying bioactive influenza virus particles. It was validated with both purified and complex matrices. Finally, an influenza viral production kinetic was monitoredonlinefor three days. This novel online tool enabled the access in real-time to total bioactive viral particles from early production phases (8hpi).
Publisher
Cold Spring Harbor Laboratory
Reference45 articles.
1. Monitoring lentiviral vector production kinetics using online permittivity measurements;Biochemical Engineering Journal,2011
2. SPR-Based Detection of ASF Virus in Cells;International Journal of Molecular Sciences,2022
3. Quantification and simultaneous evaluation of the bioactivity of antibody produced in CHO cell culture — The use of the ectodomain of Fc RI and surface plasmon resonance-based biosensor;Molecular Immunology,2017
4. PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSES
5. Durous L , Julien T , Padey B , Traversier A , Rosa-Calatrava M , Blum LJ , Marquette CA , Petiot E. 2019a. SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring. Vaccine 37.